Patents by Inventor William Rideout

William Rideout has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230372979
    Abstract: A tool for clearing debris out of gaps between wooden or composite boards in a deck is provided, including a slanted blade, an optional horizontal guide plate, and an attachment point for coupling with a handle, vacuum cleaner tube, or leaf blower tube. In preferred operation, the tool is pushed along a deck gap, with the blade protruding ahead and dislodging the debris from the deck gap, up onto the deck to be removed. Other features in certain embodiments might include a detachable blade, a brush attachment, or a nozzle attachment.
    Type: Application
    Filed: July 20, 2022
    Publication date: November 23, 2023
    Inventor: LEIF WILLIAM RIDEOUT
  • Patent number: 7622630
    Abstract: Chimeric nonhuman mammals useful as inducible spontaneous cancer models are disclosed. The nonhuman mammals are obtained by introducing one or more genetically modified embryonic stem (ES) cells into an early stage embryo, and then implanting the manipulated embryo into a surrogate mother. The ES cells contain a recombinant oncogene, and also may contain a genetic mutation that deletes or inactivates a tumor suppressor gene. Models of different types of cancer are produced by introducing different combinations of genetic mutations into the ES cells that are introduced into the early stage embryo.
    Type: Grant
    Filed: August 27, 2004
    Date of Patent: November 24, 2009
    Assignee: AVEO Pharmaceuticals, Inc.
    Inventors: Joerg Heyer, Murray Robinson, William Rideout, III, Ronald Depinho, Steven C. Clark, Yinghui Zhou, Tyler Jacks, Ronan C. O'Hagan
  • Publication number: 20090165150
    Abstract: The invention provides an improved directed complementation method for generating a conditionally tumorigenic mouse cell. In a directed complementation method, the tumorigenicity of a conditionally tumorigenic mouse cell depends on either the expression of an inducible recombinant oncogene or the expression of a recombinant gene of interest that functionally complements an uninduced recombinant oncogene. The invention provides a method of producing a tumorigenic mouse cell containing an uninduced oncogene, a recombinant gene of interest that functionally complements the uninduced oncogene, and a Cre-ER system capable of excising the recombinant gene of interest. When the Cre-ER system is activated, the recombinant gene of interest is excised. From the effect on the mouse cell it is possible to determine whether the recombinant gene of interest is a tumor maintenance gene.
    Type: Application
    Filed: December 21, 2007
    Publication date: June 25, 2009
    Inventors: Yinghui Zhou, William Rideout, III, Joerg Heyer, Murray Robinson
  • Publication number: 20070292948
    Abstract: Chimeric nonhuman mammals useful as inducible spontaneous cancer models are disclosed. The nonhuman mammals are obtained by introducing one or more genetically modified embryonic stem (ES) cells into an early stage embryo, and then implanting the manipulated embryo into a surrogate mother. The ES cells contain a recombinant oncogene, and also may contain a genetic mutation that deletes or inactivates a tumor suppressor gene. Models of different types of cancer are produced by introducing different combinations of genetic mutations into the ES cells that are introduced into the early stage embryo.
    Type: Application
    Filed: August 27, 2004
    Publication date: December 20, 2007
    Applicant: GEN-PATH PHARMACEUTICALS, INC
    Inventors: Joerg Heyer, Murray Robinson, William Rideout, Ronald Depinho, Steven Clark, Yinghui Zhou, Tyler Jacks
  • Publication number: 20030228293
    Abstract: A method of correcting of treating a genetic disorder by combining therapeutic cloning and gene therapy.
    Type: Application
    Filed: March 7, 2003
    Publication date: December 11, 2003
    Applicants: Whitehead Institute for Biomedical Research, The General Hospital Corporation
    Inventors: William Rideout, Konrad Hochedlinger, Michael Kyba, Rita Perlingeiro, George Q. Daley, Rudolf Jaenisch
  • Patent number: 5034678
    Abstract: A system for measuring the frequency response of an electrooptic device, such as an optical detector, includes an optical amplifier for generating an optical white noise spectrum that is delivered to the detector. In a first embodiment, an optical amplifier or a luminescent fiber amplifier generates a white noise signal due to spontaneous-spontaneous beat noise emission, while a second embodiment utilizes the signal-spontaneous and spontaneous-spontaneous beat noise emissions generated by an optical amplifier driven by a laser source. The frequency response of the detector is determined from a measurement of the detected noise signal wherein any roll-off in the response must be due to the detector since the originally generated noise spectrum is flat.
    Type: Grant
    Filed: July 14, 1989
    Date of Patent: July 23, 1991
    Assignee: GTE Laboratories Incorporated
    Inventors: Elliot Eichen, John Schlafer, William Rideout, John McCabe